Galan Lithium Limited
Galan Lithium Limited (GLN.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Galan Lithium Limited (GLN.AX), covering cash flow, earnings, and balance sheets.
Galan Lithium Limited (GLN.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Galan Lithium Limited GLN.AX financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $941.00 | $0.00 | $3622.00 | $0.00 |
| Cost of Revenue | $0.00 | $44408.00 | $147490.00 | $25415.00 |
| Gross Profit | $941.00 | -$44408.00 | -$143868.00 | -$25415.00 |
| Gross Profit Ratio | $1.00 | $0.00 | -$39.72 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.63M | $4.87M | $4.97M | $3.28M |
| Operating Expenses | $3.63M | $4.55M | $4.97M | $3.28M |
| Total Costs & Expenses | $3.63M | $4.55M | $5.12M | $3.30M |
| Interest Income | $0.00 | $0.00 | $1.003M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $44567.00 | $44408.00 | $147490.00 | $25415.00 |
| EBITDA | -$3.79M | -$4.87M | -$4.51M | -$3.28M |
| EBITDA Ratio | -$4032.84 | $0.00 | -$1373.42 | $0.00 |
| Operating Income | -$3.63M | -$4.91M | -$5.12M | -$3.30M |
| Operating Income Ratio | -$3856.22 | $0.00 | -$1414.14 | $0.00 |
| Other Income/Expenses (Net) | -$1.33M | $363207.00 | $34307.00 | $342603.00 |
| Income Before Tax | -$4.95M | -$4.55M | -$4.66M | -$2.96M |
| Income Before Tax Ratio | -$5265.33 | $0.00 | -$1285.22 | $0.00 |
| Income Tax Expense | $0.00 | $2.00 | $0.00 | -$5.00 |
| Net Income | -$4.95M | -$4.55M | -$4.66M | -$2.96M |
| Net Income Ratio | -$5265.33 | $0.00 | -$1285.22 | $0.00 |
| EPS | -$0.01 | -$0.01 | -$0.01 | -$0.010 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.010 |
| Weighted Avg Shares Outstanding | $405.95M | $347.39M | $310.09M | $305.35M |
| Weighted Avg Shares Outstanding (Diluted) | $405.94M | $347.39M | $310.09M | $305.35M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q2 2023 to $941.00 in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to N/A in Q2 2023. Operating income hit -$3.63M last quarter, sustaining a consistent -385622% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$3.79M. Net income dropped to -$4.95M, while earnings per share reached -$0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan